- TXG -0.78%
We Think Some Shareholders May Hesitate To Increase 10x Genomics, Inc.'s (NASDAQ:TXG) CEO Compensation
Yahoo Finance · 2 weeks ago
Open | 19.90 |
High | 20.36 |
Low | 19.40 |
Mkt Cap | 2.37B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 19.98 |
52 Wk. Low | 19.34 |
52 Wk. High | 63.57 |
Related stocks
American biotechnology company
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 141.01M | 5.00% ▲ |
Net Income | -59.95M | - |
Diluted EPS | -0.50 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.48 | - |
Q1 2024 | -$0.50 | -$0.50 |
Q4 2023 | -$0.36 | -$0.41 |
S&P 500^GSPC | 5,482.59+9.36 (+0.17%) |
Dow 30^DJI | 38,768.82-9.28 (-0.02%) |
Nasdaq^IXIC | 17,864.99+7.97 (+0.04%) |
135.87+3.73% | |
173.01+7.94% | |
Chewy, Inc.CHWY | 25.80+13.11% |